UBE2B and esophageal adenocarcinoma: In a study that aimed to construct a competing endogenous RNA (ceRNA) network for esophageal adenocarcinoma (ESAD), Ubiquitin Conjugating Enzyme E2 B (UBE2B) was identified as a prognostic factor that could predict patient survival outcomes, implicating UBE2B as a potential marker for prognosis in ESAD (12).